Uploads
Contact
/
Login
Upload
Search Results for 'Guidance For Clinical Investigators Sponsors And Irbs Investigational '
Guidance for Clinical Investigators Sponsors and IRBs Investigational New Drug A
natalia-silvester
Contains Nonbinding Recommendations Information Sheet Guidance For IRBs Clinical Investigators
jane-oiler
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors
cheryl-pisano
Guidance for IRBs Clinical Investigators and Sponsors Considerations When Transf
stefany-barnette
Guidance on legislation Clinical investigations of medical devices guidance for investigators
luanne-stotts
Pamela Harris, M.D. Percy Ivy, M.D
min-jolicoeur
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs
pamella-moone
Quality Issues for Clinical Trial Materials
min-jolicoeur
Information Sheet Guidance for Sponsors Clinical Inves
sherrill-nordquist
Guidance for Sponsors, Institutional Review Boards, Clinical Investiga
cheryl-pisano
Contract Research organizations
calandra-battersby
Stephen A. Bean, PharmD
lois-ondreau
1 King & Spalding May 22, 2014
marina-yarberry
Guidance for Industry CGMP for Phase Investigational Drugs U
olivia-moreira
Guidance for Industry Codevelopment of Two or More New Investigational Drugs for Use in
alida-meadow
Guidance for Industry Considerations for the Design of Early Phase Clinical Trials of
briana-ranney
Terminologies in Clinical Research
trish-goza
Steven Taylor Chief Executive Officer
liane-varnes
C entral IRBs
myesha-ticknor
Guidance for Industry Formal Meetings Between the FDA and Sponsors or Applicants U
marina-yarberry
Robotic, Laparoscopic and Open Surgery for Gastric Cancer Compared on Surgical, Clinical
tatiana-dople
Orientation for New Clinical Research PERSONNEL
aaron
Preparing for an FDA Inspection
tawny-fly
Preparing for an FDA Inspection
min-jolicoeur
1
2
3
4
5
6